For example, GINY and DQW from α-lactalbumin could alleviate NAFLD by activating the peroxisome proliferator-activated receptor α (PPARα) pathway to decrease lipid deposition and oxidative stress [26,27]. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.